Learning Objectives:

1. We will define the current standards for diagnosis and risk prediction in cancer therapy cardiotoxicity, with a specific 
    focus on doxorubicin and trastuzumab, sunitinib, and radiation therapy..

2. We will assess the role of imaging markers in risk prediction and diagnosis.

3. We will examine the role of biomarkers in risk prediction and diagnosis.


Session date: 
Friday, January 17, 2020 - 12:00pm to 1:00pm
W-632, The Medical Center
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Bonnie Ky, MD, MSCE